Accordingly, we found increased HDAC3 levels in the cortex of AD patients at Braak stages III–IV, as compared to control individuals (Figure 1b), along with a significant reduction in acetylated histone H3 (acetyl‐H3) levels (Figure 1c). This evidence concerns the gene HDAC3 and Alzheimer disease.